Clinics Ink $2M FCA Deal In Reimported Drugs Case
A pair of Tennessee-based orthopedic clinics will shell out a combined $1.85 million to settle a whistleblower's False Claims Act allegations that they illegally bought lower-cost prescription drugs from foreign sources...To view the full article, register now.
Already a subscriber? Click here to view full article